These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 38095784)
1. Association of radiotherapy for prostate cancer and second primary colorectal cancer: a US population-based analysis. Tang W; Zhou LJ; Zhang WQ; Jia YJ; Ge MW; Hu FH; Chen HL Tech Coloproctol; 2023 Dec; 28(1):14. PubMed ID: 38095784 [TBL] [Abstract][Full Text] [Related]
2. Second primary colorectal cancer after the initial primary colorectal cancer. Yang L; Xiong Z; Xie QK; He W; Liu S; Kong P; Jiang C; Xia X; Xia L BMC Cancer; 2018 Sep; 18(1):931. PubMed ID: 30261873 [TBL] [Abstract][Full Text] [Related]
3. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies. Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519 [TBL] [Abstract][Full Text] [Related]
4. Second primary colorectal cancer in adults: a SEER analysis of incidence and outcomes. Lun W; Luo C BMC Gastroenterol; 2023 Jul; 23(1):253. PubMed ID: 37495987 [TBL] [Abstract][Full Text] [Related]
5. The risk and survival outcome of subsequent primary colorectal cancer after the first primary colorectal cancer: cases from 1973 to 2012. Yang J; Du XL; Li S; Wu Y; Lv M; Dong D; Zhang L; Chen Z; Wang B; Wang F; Shen Y; Li E; Yi M; Yang J BMC Cancer; 2017 Nov; 17(1):783. PubMed ID: 29166866 [TBL] [Abstract][Full Text] [Related]
6. Association of Radiotherapy for Rectal Cancer and Second Gynecological Malignant Neoplasms. Guan X; Wei R; Yang R; Lu Z; Liu E; Zhao Z; Chen H; Yang M; Liu Z; Jiang Z; Wang X JAMA Netw Open; 2021 Jan; 4(1):e2031661. PubMed ID: 33416884 [TBL] [Abstract][Full Text] [Related]
7. Risk of second primary malignancies associated with radiotherapy in prostate cancer patients: competing risk analysis. Wu Y; Li Y; Han C; Chong Y; Kang K; Liu Z; Zhang F Future Oncol; 2022 Feb; 18(4):445-455. PubMed ID: 35018785 [TBL] [Abstract][Full Text] [Related]
8. Risk and prognosis of second corpus uteri cancer after radiation therapy for pelvic cancer: A population-based analysis. Yu G; Wei R; Li S; Wang Y; Liu H; Chen T; Guan X; Wang X; Jiang Z Front Oncol; 2022; 12():957608. PubMed ID: 36249002 [TBL] [Abstract][Full Text] [Related]
9. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis. Moschini M; Zaffuto E; Karakiewicz PI; Andrea DD; Foerster B; Abufaraj M; Soria F; Mattei A; Montorsi F; Briganti A; Shariat SF Eur Urol; 2019 Feb; 75(2):319-328. PubMed ID: 30293908 [TBL] [Abstract][Full Text] [Related]
10. Radiation therapy at the end of life: a population-based study examining palliative treatment intensity. Kress MA; Jensen RE; Tsai HT; Lobo T; Satinsky A; Potosky AL Radiat Oncol; 2015 Jan; 10():15. PubMed ID: 25582217 [TBL] [Abstract][Full Text] [Related]
11. Ascertainment of postprostatectomy radiotherapy for prostate cancer in the Surveillance, Epidemiology, and End Results database. Wang K; Sheets NC; Basak R; Chen RC Cancer; 2016 Oct; 122(19):3069-74. PubMed ID: 27352280 [TBL] [Abstract][Full Text] [Related]
12. The characteristics of bladder cancer after radiotherapy for prostate cancer. Abern MR; Dude AM; Tsivian M; Coogan CL Urol Oncol; 2013 Nov; 31(8):1628-34. PubMed ID: 22575239 [TBL] [Abstract][Full Text] [Related]
13. Increased Burden of Second Bladder Cancer and Rectal Cancer in Prostate Cancer Treated With Radiotherapy: Results From Surveillance, Epidemiology, and End Results. Lin J; Zhan X; Chen R; Chen T; Jiang M; Li Y; Liu X; Chen G; Fu B Cancer Control; 2023; 30():10732748231177544. PubMed ID: 37196346 [TBL] [Abstract][Full Text] [Related]
14. External Beam Radiation Therapy With a Brachytherapy Boost Versus Radical Prostatectomy in Gleason Pattern 5 Prostate Cancer: A Population-Based Cohort Study. Wang C; Kishan AU; Kamrava M; Steinberg ML; King CR Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1045-1052. PubMed ID: 28721887 [TBL] [Abstract][Full Text] [Related]
15. Risk and prognosis of secondary thoracic cancers after radiation therapy for esophageal cancer. Yi H; Li S; Lin Y; Li F; Wang S; Jin D; Lv Z; Fu L; Mao Y J Gastroenterol Hepatol; 2023 Jun; 38(6):930-939. PubMed ID: 36811199 [TBL] [Abstract][Full Text] [Related]
16. Risk and prognosis of secondary esophagus cancer after radiotherapy for breast cancer. Sun Q; Chen Y; Li T; Ni B; Zhu X; Xu B; Li J Sci Rep; 2023 Mar; 13(1):3968. PubMed ID: 36894590 [TBL] [Abstract][Full Text] [Related]
17. Incidence and risk outcomes of second primary malignancy of patients with post-operative colorectal cancer. Yang J; Wu F; An H; Gan H Int J Colorectal Dis; 2023 Mar; 38(1):88. PubMed ID: 36995483 [TBL] [Abstract][Full Text] [Related]
18. Propensity-weighted long-term risk of urinary adverse events after prostate cancer surgery, radiation, or both. Jarosek SL; Virnig BA; Chu H; Elliott SP Eur Urol; 2015 Feb; 67(2):273-80. PubMed ID: 25217421 [TBL] [Abstract][Full Text] [Related]
19. Neighborhood and Individual Socioeconomic Disadvantage and Survival Among Patients With Nonmetastatic Common Cancers. Cheng E; Soulos PR; Irwin ML; Cespedes Feliciano EM; Presley CJ; Fuchs CS; Meyerhardt JA; Gross CP JAMA Netw Open; 2021 Dec; 4(12):e2139593. PubMed ID: 34919133 [TBL] [Abstract][Full Text] [Related]
20. Inverse probability of treatment-weighted competing risks analysis: an application on long-term risk of urinary adverse events after prostate cancer treatments. Bolch CA; Chu H; Jarosek S; Cole SR; Elliott S; Virnig B BMC Med Res Methodol; 2017 Jul; 17(1):93. PubMed ID: 28693428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]